Neurology Minute

BTK Inhibitors in Multiple Sclerosis Treatment - Part 3

Informações:

Synopsis

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985   https://www.nejm.org/doi/full/10.1056/NEJMoa2415988